Who is sponsoring NCT02966704?

NCT02966704 is sponsored by Wageningen University.

What drugs are being tested in NCT02966704?

Interventions in NCT02966704: intrinsically labeled milk protein.

What condition does NCT02966704 study?

NCT02966704 studies Biological Availability.

Is NCT02966704 still recruiting?

NCT02966704 is currently completed. Last updated 14 December 2017.

Last reviewed 2017-12-14 · How we verify

NCT02966704

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stable Isotope Method to Assess Dietary Protein Quality

Completed NA Last updated 14 December 2017

What this trial tests

NA trial testing intrinsically labeled milk protein in Biological Availability in 10 participants. Completed in 21 November 2016.

Timeline

21 July 2016

Primary endpoint
21 November 2016

21 November 2016

Quick facts

Lead sponsor	Wageningen University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	basic science
Enrollment	10
Start date	21 July 2016
Primary completion	21 November 2016
Estimated completion	21 November 2016

Drugs / interventions tested

intrinsically labeled milk protein

Conditions studied

Biological Availability — all drugs for Biological Availability →

Sponsor

Wageningen University

Who can join

Adults 18 to 35, any sex, with Biological Availability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The evaluation of protein quality has been identified as the top priority question by the Food and Agricultural Organization (FAO) of the United Nations. However, the current available methods do not precisely estimate protein quality, or need invasive procedures. The proposed 'dual tracer approach' is a non-invasive method to evaluate protein quality in humans. The present project characterizes the use of 15N-intrinsically-labelled milk protein as a reference-protein for development a non-invasive method that can be used to assess protein quality in human subjects

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Blood 15N:13C Enrichment Ratios Are Proportional to the Ingested Quantity of Protein with the Dual-Tracer Approach for Determining Amino Acid Bioavailability in Humans.
van der Wielen N, Khodorova NV, Gerrits WJJ, Gaudichon C, et al · · 2020 · cited 10× · PMID 32710787 · DOI 10.1093/jn/nxaa205

Verify or expand the search:

Other Wageningen University trials

Trials by the same sponsor.

NCT07361406 — SweetSpot - The Effect of Non-nutritive Sweeteners on Health · NA · recruiting
NCT07421466 — Umami Taste Intensity and Meal Intake · NA · completed
NCT07075991 — Uptake and Excretion of a Single Dose of Oral 14C-labelled Polystyrene Microplastics in Healthy Volunteers · NA · completed
NCT07059117 — Umami Taste Intensity and ad Libitum Meal Intake · NA · completed
NCT06750497 — Forearm Immobilization in T2D · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02966704 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wageningen University
Last refreshed: 14 December 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02966704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing